Data is not available at this time.
D & M Company Co., Ltd. operates in the specialty business services sector, focusing on management support for medical and long-term care welfare professionals in Japan. The company provides a suite of services including fineness, consulting, and HR solutions, catering to the growing demand for operational efficiency in healthcare and welfare sectors. Its niche positioning allows it to address specific pain points in workforce management and institutional optimization within these industries. The firm’s localized expertise in Osaka and broader Japanese markets strengthens its competitive edge, though its relatively recent founding in 2015 suggests it is still scaling its market penetration. With Japan’s aging population driving demand for long-term care services, D & M is well-placed to benefit from structural tailwinds, though it faces competition from larger, diversified service providers. The company’s ability to integrate consulting with HR solutions differentiates its offering, but its small market cap indicates it remains a minor player in the industrials sector.
In FY 2024, D & M reported revenue of JPY 1.19 billion, with net income of JPY 177.4 million, translating to a diluted EPS of JPY 115.63. Operating cash flow was negative at JPY -782.7 million, likely due to working capital adjustments or strategic investments, while capital expenditures were minimal at JPY -2.3 million. The company’s profitability margins appear stable, but cash flow volatility warrants monitoring.
The company’s net income of JPY 177.4 million reflects modest earnings power, though its negative operating cash flow raises questions about short-term liquidity management. With limited capital expenditures, D & M’s capital efficiency hinges on its ability to scale consulting and HR services without significant additional investment. The JPY 40 dividend per share suggests a commitment to shareholder returns, but sustainability depends on improving cash generation.
D & M’s balance sheet shows JPY 480 million in cash against total debt of JPY 7.29 billion, indicating a leveraged position. The high debt load relative to cash reserves may constrain financial flexibility, though the company’s market cap of JPY 1.95 billion suggests equity markets are pricing in growth potential. Investors should assess refinancing risks given the debt-to-equity imbalance.
The company’s growth trajectory is tied to Japan’s healthcare and welfare sector expansion, but its FY 2024 revenue of JPY 1.19 billion reflects modest scale. The JPY 40 dividend per share implies a yield that may appeal to income-focused investors, though payout sustainability depends on earnings stability. Future growth may require geographic or service-line diversification.
With a market cap of JPY 1.95 billion and a beta of -0.25, D & M exhibits low correlation to broader markets, possibly due to its niche focus. The P/E ratio derived from its JPY 115.63 EPS suggests modest valuation multiples, though investors may demand higher returns given the company’s leverage and cash flow challenges.
D & M’s specialization in medical and welfare management services positions it to capitalize on Japan’s demographic trends, but its small size and debt burden pose risks. Strategic partnerships or service innovation could enhance its market position, while improving cash flow stability is critical for long-term viability. The outlook remains cautiously optimistic, contingent on execution in a competitive landscape.
Company filings, market data
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |